Document is current
Any future updates will be listed below
-
Authors
Tao, Rachel E. https://orcid.org/0000-0002-4985-0546
Pixley, Jessica N. https://orcid.org/0000-0001-9049-1808
Kontzias, Christina L. https://orcid.org/0000-0002-0715-9204
Feldman, Steven R. https://orcid.org/0000-0002-0090-6289
- License Information
-
More Information
Article History
Received: 10 August 2023
Revised: 10 August 2023
Accepted: 16 September 2023
First Online: 12 December 2023
Declarations
:
: Dr. Steven Feldman has received research, speaking and/or consulting support from AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Eurofins, Forte, Galderma, Helsinn, Janssen, Leo Pharma, Micreos, Mylan, Novartis, Ono, Ortho Dermatology, Pfizer, Regeneron, Samsung, Sanofi, Sun Pharma, UCB, Verrica, Voluntis, and vTv Therapeutics. He is founder and part owner of Causa Research and holds stock in Sensal Health. Rachel Tao, Jessica Pixley, and Christina Kontzias have no conflicts of interest to disclose.
